Attending the World EPA Congress in Amsterdam on March 5 - 6 and curious about how health equity data is shaping HTA outcomes? Trinity's session, "Eyes Wide Open: How is Health Equity Data Really Impacting HTA Outcomes?" will delve into this critical topic. Mary Fletcher-Louis and Andreia Ribeiro will explore how agencies are incorporating health equity into their assessments and when it becomes a pivotal factor in decision-making. Key Takeaways: Which HTA agencies are requesting health equity data? How is health equity influencing recommendations? The rise of DCEA modeling and its insights. Be sure to visit Trinity at stand 45 to hear from our experts and see our HTA Vision demo live.
Trinity Life Sciences
Business Consulting and Services
Waltham, MA 109,565 followers
About us
With almost 30 years of expertise, a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights and analytics to help life science executives with clinical and commercial decision-making. We serve over 300 pharmaceutical, biotech and medical device clients, helping them develop the right drugs and devices for today’s market and optimize them once in market. In 2023, the company worked on 75% of all new drug launches and provides ongoing, in-depth, high value thought leadership that helps shape the industry. With a diverse staff of over 1,200 employees and 11 global offices across the U.S., Europe and Asia, Trinity continues to grow both organically and through acquisitions. These acquisitions included BluePrint Research Group, CBPartners, TGaS Advisors, Bell Canyon and D Cube Analytics, the latter of which dramatically leap-frogged Trinity to the leading provider of go-to-market analytics and AI to biopharma companies. Trinity has also entered into a transformative partnership with Bain & Company that has strategically advanced Trinity’s mission to revolutionize the pharmaceutical commercial model. Ultimately, we know that every decision our clients make impacts a life, and when we help our clients achieve their goals, the world benefits.
- Website
-
https://trinitylifesciences.com/
External link for Trinity Life Sciences
- Industry
- Business Consulting and Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Waltham, MA
- Type
- Privately Held
- Founded
- 1996
- Specialties
- consulting, healthcare, lifesciences, strategy, valuation, primary market research, and advanced analytics
Locations
Employees at Trinity Life Sciences
-
David Uffer
Managing Director, MedTech Trinity LifeSciences
-
Julie A. Bayley
Associate Director @ TRINITY | Expert in Marketing Communications & Qualitative Research
-
Anne Whitaker
Independent Director | Private Equity and Board Advisor l Board of Directors Chairwoman l Experienced Biotech CEO and Large Pharma C-Suite Leader
-
Peter Bittinger
SVP, Applications and Platform Development at Trinity Life Sciences
Updates
-
Industry Veteran Joins Trinity Life Sciences. Meet Christian Hoyvald, Solutions Strategist, Customer Engagement.
-
Are you ready to take a bite out of IC administration complexity? Join Trinity Life Sciences for a virtual lunch and learn where incentive compensation (IC) experts, Miles Scotcher and James Castello will showcase Trinity’s proprietary IC administration platform and guide you through best practices in IC administration and common watchouts.
This content isn’t available here
Access this content and more in the LinkedIn app
-
Register for our webinar: https://bit.ly/42K9SoD Join a team of cross-functional experts from Trinity Life Sciences for a lively panel discussion on how to approach early commercial assessment with insight from various perspectives. The team will share real-life examples highlighting what life sciences companies need to be thinking about and common pitfalls they must avoid to navigate the early asset evaluation journey with confidence. Two additional sessions will be offered: February 26 – 16:00 (UTC +8:00) – Asia/Shanghai February 26 – 15:00 CET – Europe/Berlin Featured experts: Bami Oshinowo, Julie Fleming, Lauren Peters Radeck and Monique Marsh.
-
-
“Trinity Life Sciences is honored to collaborate with The Galien Foundation in establishing this distinguished award category dedicated to advancing health equity,” said Leslie Orne, President & CEO Trinity Life Sciences. Read more in the press release: https://lnkd.in/eAgrw9Dn
The Galien Foundation is proud to announce a new #PrixGalien UK award category in partnership with Trinity Life Sciences, recognizing outstanding contributions in health equity innovation. Together, we’re empowering visionaries who are shaping the next era of healthcare. Read more here: https://galien.org/41hv9ES
-
-
Meet Nate Robertson, Executive Director of Patient Support Services for TGaS Advisors, a division of Trinity Life Sciences.
-
Are you ready to take a bite out of IC administration complexity? Join Trinity Life Sciences for a virtual lunch and learn where incentive compensation (IC) experts, Miles Scotcher and James Castello will demonstrate Trinity's proprietary IC administration tool--a modular, "one-stop shop" for effective incentive compensation management for the life sciences. Register now: https://bit.ly/3QhuixP
-
-
“Sometimes this is being seen as just an IT migration — but no, if you’re just migrating, you’re missing the strategic importance of this. A lot of leaders are starting to realize this is a much bigger decision, and they need to think through the choices, the timing and the approach to set up for a very different world.” - Nancy Phelan, Senior Vice President & Head of Customer Engagement. Read the full Pharmavoice article to learn more: https://lnkd.in/eptivrrF
-
-
"I think the next several months will remain a bit of a rollercoaster for industry, as we better understand the administration and its appointees’ positions on each of these topics. In the meantime, pharma will need to navigate uncertainty with preparation – we know these negotiations have been influenced by evidence and the evidence has been graded by its robustness." - Monica Martin de Bustamante Read the article to learn more: https://lnkd.in/gM4bFxWY
-
-
Meet with Trinity experts at World EPA Congress on March 5 - 6 in Amsterdam to discuss best practices, tips and key considerations for global and U.S. access and value. Book a meeting today: https://lnkd.in/e8nPgjX8
-